UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare Study

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3368-3375

2012

Volltextzugriff (PDF)

Lava-ice interactions during historical eruptions of Veniaminof Volcano, Alaska and the potential for meltwater floods and lahars

Natural hazards (Dordrecht), 2023, Vol.115 (1), p.73-106

2023

Volltextzugriff (PDF)

Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma

Journal of clinical oncology, 2004-08, Vol.22 (15), p.3046-3052

2004

Volltextzugriff (PDF)

Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516—The Southwest Oncology Group

Journal of clinical oncology, 2009-01, Vol.27 (1), p.114-119

2009

Volltextzugriff (PDF)

Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma: Southwest Oncology Group Study 0014

Journal of clinical oncology, 2008-05, Vol.26 (14), p.2258-2263

2008

Volltextzugriff (PDF)

Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial

Blood, 2013-05, Vol.121 (18), p.3547-3553

2013

Volltextzugriff (PDF)

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8447-8452

2005

Volltextzugriff (PDF)

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

British journal of haematology, 2013-04, Vol.161 (1), p.76-86

2013

Volltextzugriff (PDF)

Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911

Journal of clinical oncology, 2006-09, Vol.24 (25), p.4143-4149

2006

Volltextzugriff (PDF)

Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2

PloS one, 2014-06, Vol.9 (6), p.e95184

2014

Volltextzugriff (PDF)

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

Haematologica (Roma), 2012-06, Vol.97 (6), p.937-942

2012

Volltextzugriff (PDF)

Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular Lymphoma

Journal of clinical oncology, 2005-07, Vol.23 (19), p.4390-4398

2005

Volltextzugriff (PDF)

Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001

Journal of clinical oncology, 2020-09, Vol.38 (26), p.3003-3011

2020

Volltextzugriff (PDF)

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

Blood, 2015-01, Vol.125 (2), p.236-241

2015

Volltextzugriff (PDF)

Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

The New England journal of medicine, 2013-10, Vol.369 (18), p.1681-1690

2013

Volltextzugriff (PDF)

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

Molecular cancer therapeutics, 2005-12, Vol.4 (12), p.1867-1879

2005

Volltextzugriff (PDF)

Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas

Laboratory investigation, 2003-02, Vol.83 (2), p.271-285

2003

Volltextzugriff (PDF)

Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma

Laboratory investigation, 2007-10, Vol.87 (10), p.979-997

2007

Volltextzugriff (PDF)

Phase 2 Trial of Combined Cisplatin, Etoposide, Gemcitabine, and Methylprednisolone (PEGS) in Peripheral T-Cell Non-Hodgkin Lymphoma: Southwest Oncology Group Study S0350

Cancer, 2013-01, Vol.119 (2), p.371-379

2013

Volltextzugriff (PDF)

Phase III Randomized Intergroup Trial of Subtotal Lymphoid Irradiation Versus Doxorubicin, Vinblastine, and Subtotal Lymphoid Irradiation for Stage IA to IIA Hodgkin’s Disease

Journal of clinical oncology, 2001-11, Vol.19 (22), p.4238-4244

2001

Volltextzugriff (PDF)

Diffuse aggressive lymphoma

Hematology, 2004, Vol.2004 (1), p.221-236

2004

Volltextzugriff (PDF)

What Will We Have Made of Literacy?

College composition and communication, 2018-02, Vol.69 (3), p.494-502

Miller, Thomas P.

2018

Volltextzugriff (PDF)

A volcanic activity alert-level system for aviation: review of its development and application in Alaska

Natural hazards (Dordrecht), 2013-12, Vol.69 (3), p.1519-1533

2013

Volltextzugriff (PDF)

Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Haematologica (Roma), 2016-07, Vol.101 (7), p.e295-e298

2016

Volltextzugriff (PDF)

1 – 25 von 5.036

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.188)
Mit Volltextzugriff
(4.277)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare Study

Lava-ice interactions during historical eruptions of Veniaminof Volcano, Alaska and the potential for meltwater floods and lahars

Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma

Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516—The Southwest Oncology Group

Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma: Southwest Oncology Group Study 0014

Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911

Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular Lymphoma

Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas

Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma

Phase 2 Trial of Combined Cisplatin, Etoposide, Gemcitabine, and Methylprednisolone (PEGS) in Peripheral T-Cell Non-Hodgkin Lymphoma: Southwest Oncology Group Study S0350

Phase III Randomized Intergroup Trial of Subtotal Lymphoid Irradiation Versus Doxorubicin, Vinblastine, and Subtotal Lymphoid Irradiation for Stage IA to IIA Hodgkin’s Disease

Diffuse aggressive lymphoma

What Will We Have Made of Literacy?

A volcanic activity alert-level system for aviation: review of its development and application in Alaska

Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

Suchergebnisse filtern